Executives with Sybron Dental Specialties Inc. are moving closer to the beach this fall.
Sybron, a maker of braces, fillings and other dental products, is planning to move its headquarters to Newport Beach from Orange in September.
Sybron has leased 18,500 square feet of space at 100 Bayview Circle. The office complex faces Bristol Street near the San Joaquin Hills (73) Toll Road. Financial terms of the 5.5-year lease weren’t disclosed.
The dental products company is planning to move Chief Executive Floyd Pickrell Jr. and nearly 40 other workers to the new office in September, said John Trapani, vice president of human resources.
Sybron, which now occupies about 114,600 square feet in two buildings on Collins Avenue in Orange, was running out of space there, Trapani said.
Only the executive operations will be going to Bayview, Trapani said.
“We stay here,” he said. “This is the worldwide headquarters for the operating units, and we do some manufacturing here.”
Sybron’s two major units are Kerr Dental, which makes restorative dental materials and devices used in root canals and Ormco, producer of orthodontic supplies such as bracket braces, bands, crowns and elastics.
Shane Wilder, a broker in Studley Inc.’s Irvine office, represented Sybron. Brian Garbutt of Lee & Associates Commercial Real Estate Services Inc. in Newport Beach represented landlord American Spectrum Realty Inc.
Sybron’s been looking for a new corporate home for a while. The company “looked at a lot of properties” before deciding to lease space on Bayview, Trapani said.
So is the new headquarters closer to executive homes?
Trapani declined to answer, saying only “I don’t anticipate we will lose anyone. Many of us live in the OC area.”
Sybron is one of Orange County’s larger public companies, with a market value of $1.5 billion at recent check.
It recently raised its 2005 sales guidance to $630 million to $640 million, up from a prior forecast of $620 million to $630 million. The company said its profits are expected to be $68 million to $71.2 million this year, in-line with a previous estimate.
Sybron saw “positive trends” in its business in the quarter ended March 31, Pickrell said.
The company posted strong sales of its new Damon 3 line of braces as well as self-adhesive dental cements and composites, he said.
Newly launched dental products, according to Pickrell, generated more than $7 million, or 2%, of revenue for Sybron during its past two quarters.
The company has counted on sales growth from several trends, including longer life expectancy, vanity and a desire to keep natural teeth longer.